New arthritis drug takes first step in human testing
Disease control
Completed
This was the first study in humans to test a new drug called SOL-116 for rheumatoid arthritis. Researchers gave single doses to 56 healthy volunteers and arthritis patients to check if it was safe and how the body processes it. The main goal was to understand side effects and det…
Phase: PHASE1 • Sponsor: Lipum AB • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC